Psilera Partners with Hesperos to advance PSIL-006 for Dementia
09 Jun 2025 //
PR NEWSWIRE
Hesperos Wins ACC.25 Pitch Competition, FDA Plans Animal Testing
01 May 2025 //
BUSINESSWIRE
Hesperos & UCF Develop Human-on-a-Chip® For Opioid Crisis
09 Jan 2025 //
BUSINESSWIRE
Hesperos And UCF Develop iPSC-Derived Myelination Model
24 Oct 2024 //
BUSINESSWIRE
Hesperos Appoints Lawrence Florin As CEO To Lead Growth
22 Oct 2024 //
BUSINESSWIRE
Hesperos Supports Phase II Trial with Human-on-a-Chip® Technology
24 Sep 2024 //
BUSINESSWIRE
NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform
07 May 2024 //
BUSINESSWIRE
Hesperos, Inc. Appoints New Chief Executive Officer, Dr. James Kronauge
26 May 2022 //
BUSINESSWIRE